1-4 of 4
Mirjam Klaus
Close
Sort by
Journal Articles

Study of the Quantitative, Functional, Cytogenetic and Immunoregulatory Properties of Bone Marrow Mesenchymal Stem Cells in Patients with B-Cell Chronic Lymphocytic Leukemia

Charalampos Pontikoglou, Maria-Christina Kastrinaki, Mirjam Klaus, Christina H. Kalpadakis, Pavlos Katonis, Kalliopi Alpantaki, Gerasimos Pangalis, Helen Papadaki
Journal: Blood
Blood (2012) 120 (21): 3861.
https://doi.org/10.1182/blood.V120.21.3861.3861
Published: 2012
Journal Articles

Interphase FISH and Comparative Genomic Hybridization Performed in Addition to Chromosome Banding Analysis in AML with Normal Karyotype Detect Prognostically Relevant Chromosome Abnormalities.

Claudia Schoch, MD, Mirjam Klaus, MD, Susanne Schnittger, PhD, Wolfgang Hiddemann, MD, Wolfgang Kern, MD, Torsten Haferlach, MD
Journal: Blood
Blood (2004) 104 (11): 2016.
https://doi.org/10.1182/blood.V104.11.2016.2016
Published: 2004
Journal Articles

Mutations in the AML1 Gene Define an Unfavorable Subgroup in Acute Myeloid Leukemia with FAB M0.

Frank Dicker, PhD, Mirjam Klaus, MD, Torsten Haferlach, MD, Wolfgang Kern, MD, Wolfgang Hiddemann, MD, Claudia Schoch, MD, Susanne Schnittger, MD
Journal: Blood
Blood (2004) 104 (11): 4340.
https://doi.org/10.1182/blood.V104.11.4340.4340
Published: 2004
Journal Articles

AML with 11q23/ MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases

Clinical Trials & Observations
Claudia Schoch, Susanne Schnittger, Mirjam Klaus, Wolfgang Kern, Wolfgang Hiddemann, Torsten Haferlach
Journal: Blood
Blood (2003) 102 (7): 2395–2402.
https://doi.org/10.1182/blood-2003-02-0434
Published: 2003